NCT05607329View on ClinicalTrials.gov

Secondary Cytoreduction Followed by Chemotherapy Versus Chemotherapy Alone in Relapsed Ovarian Cancer After PARPi Maintenance Treatment: a Multicentre, Open-label, Randomised, Phase 3 Trial

NARecruitingINTERVENTIONAL

Enrollment

400

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

May 1, 2026

Study Completion Date

May 1, 2028

Conditions

Relapsed Ovarian Cancer

Interventions

PROCEDURE

Secondary cytoreduction

Open surgery is conducted by senior clinicians in gynecological oncology. Operation time，location and number of relapsed lesions, location and number of excised lesions, Whether achieved R0 or not, and other information are recorded.

DRUG

Chemotherapy

chemotherapy

Trial Locations (1)

310000

RECRUITING

Women's Hospital, Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors

lead

Women's Hospital School Of Medicine Zhejiang University

OTHER